An Observational Prospective Study to Assess Respiratory Syncytial Virus (RSV) Respiratory Events Among Premature Infants (32 to 35 Week Gestational Age) - Outcomes and Risk Tracking Study (The Report Study)
Endpoint Classification: -
Intervention Model: -
Primary Purpose: -
Verified 01 Nov 2012 by MedImmune, LLC
No locations available
32 to 35 WGA Infants less than six months of age by RSV season peak.